Cargando…
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
Randomized phase III trials have shown significant improvement of survival 1, 2, and 3 years after implantation of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers for patients with newly diagnosed malignant glioma. But these studies and subsequent non-phase III studies have also shown risks asso...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936684/ https://www.ncbi.nlm.nih.gov/pubmed/20706757 http://dx.doi.org/10.1007/s10143-010-0280-7 |